JP Morgan analyst Calvin Sternick maintains Universal Health Servs (NYSE:UHS) with a Neutral and lowers the price target from $152 to $144.
JP Morgan Maintains Neutral on Universal Health Servs, Lowers Price Target to $144
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.